Actavis launches latanoprost generics in Europe

Iceland-based generic drugmaker Actavis says that it has launched latanoprost eye drops in seven major European markets, immediately after the patents expired in January.

In addition to the UK, France, Sweden, Ireland, Denmark, Germany and the Netherlands, the product will be available in Finland at market formation on February 1, while Italy, Spain, Iceland, Switzerland, Hungary, Bulgaria and the Czech Republic have already launched the Actavis product.

At the same time, Actavis has launched latanoprost/timolol eye drops in Denmark, Finland and Ireland, immediately after patent expiry. The product will be marketed in Hungary and the Baltics later this month with more countries set to follow suit later this year.